Christopher J. Morl
2017
In 2017, Christopher J. Morl earned a total compensation of $1.2M as Chief Business Officer at Deciphera Pharmaceuticals, a 61% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $115,000 |
|---|---|
| Option Awards | $709,299 |
| Salary | $328,250 |
| Other | $64,142 |
| Total | $1,216,691 |
Morl received $709.3K in option awards, accounting for 58% of the total pay in 2017.
Morl also received $115K in non-equity incentive plan, $328.3K in salary and $64.1K in other compensation.
Rankings
In 2017, Christopher J. Morl's compensation ranked 8,043rd out of 14,666 executives tracked by ExecPay. In other words, Morl earned more than 45.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,043 out of 14,666 | 45th |
Division Manufacturing | 3,026 out of 5,772 | 48th |
Major group Chemicals And Allied Products | 993 out of 2,075 | 52nd |
Industry group Drugs | 777 out of 1,731 | 55th |
Industry Pharmaceutical Preparations | 613 out of 1,333 | 54th |
Source: SEC filing on April 3, 2018.
Morl's colleagues
We found two more compensation records of executives who worked with Christopher J. Morl at Deciphera Pharmaceuticals in 2017.